Top compounds associated with response to CT45A1


Feature Type Standardized
Nominal ANOVA
mRNA canertinib CTRPv2 pan-cancer AAC -0.056 0.1
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.046 0.1
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.056 0.1
mRNA pac-1 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.064 0.1
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.056 0.1
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.063 0.1
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.07 0.1
Download CSV